Clinical Trial Update: Safety of and Immune Response to an H1N1 Influenza Virus Vaccine in HIV Infected Children and Youth [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating safety and immune response of an H1N1 influenza vaccine in HIV-infected children and youth has completed with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• H1n1 Influenza Virus Infection
• HIV Infections

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections, H1N1 Influenza Virus | Phase 2 | Status: COMPLETED | Results posted: 2012-02-09